Vital Farms

Vital Farms shares rose about 5% and continued a rebound from annual lows. Drivers were the Q2 results on Aug. 6, which slightly beat revenue expectations, the reaffirmation of the full-year sales forecast of $775–800 million, and several analysts raising price targets with Benchmark rating the stock "Buy." Additional support came from the strategic focus on pasture-raised eggs rather than butter and the inclusion in value-oriented Russell indexes, which can lead to passive inflows. The company, however, still faces margin pressure and ongoing litigation. » More on de.investing.com

Vital Farms reported an adjusted loss per share of $0.47 for Q2 (expectation: -$0.44) and a 10.1% decline in revenue to $166 million, slightly below consensus. Headwinds included an industry-wide oversupply, higher costs for supply management and one-time charges related to the restructuring plan. Management reaffirmed the full-year outlook (revenue $775–800 million; adjusted EBITDA $0–10 million), called Q2 an operational trough and expects improvement in the second half; new debt financing was also secured. The stock fell about 6.2% to $11.48. » More on de.investing.com

Vital Farms fell 1.9% to $12.71 in midday trading. Main drivers are broad risk aversion in US markets and the fallout from a weak Q1 2026 report that showed a net loss, EPS of -$0.03 and a lowered full-year revenue forecast of $775–800 million. Numerous analysts subsequently cut ratings and price targets; added pressure comes from the strategic exit from the butter business, an oversupply in the egg market and increased competition from private-label brands. The stock is more than 60% below its level at the start of the year and remains vulnerable until the next quarterly report on August 6. » More on de.investing.com